We are proud to announce that Medichem´s Rivaroxaban 2.5mg, 10mg, 15mg and 20 mg DCP has been approved! … And API Rivaroxaban EU and US DMFs have been successfully filed!
We close the week with very good news! We are very happy to be part of CataloniaBio & HealthTech joining the +200 leading companies in R&D across the healthcare industry. .
Join us at Pharma Partnering Summit 2022! 📢 This week, we will be attending Pharma Partnering Summit taking place on 12th & 13th May 2022, in Brussels Meet our Chief Scientif.
This week, our #CEO and President of Medicines for Europe, Elisabeth Stampa visited the European Commission. She met and exchanged views with key members of the College of Co.
These cookies are strictly necessary for the proper functioning of the website and for the provision of services that were expressly required by the user. They are enabled by default, since the website will not function properly without these cookies.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
These cookies allow us to employ data analytics so we can measure traffic sources, see how visitors move around the site, and improve the website functionality and performance.
What Cookies are used on the website Medichem.es?
Here is an explanatory chart, detailing what cookies we used on our Website, what their objectives are and the expiration thereof.
|Own||PHPSESSID||Native PHP Cookie that allows the web to save serialized status data||Session|
|Third Party||_ga||Metrics||2 years|
|Third Party||1P_JAR||Metrics||7 days|
|Third Party||fr||It provides information to Facebook to associate functionality of Social Plugin.||90 days|
Please enable Strictly Necessary Cookies first so that we can save your preferences!